User profiles for Tihana Bicanic
Tihana BicanicSt George's University of London Verified email at sgul.ac.uk Cited by 12195 |
[HTML][HTML] Tackling the emerging threat of antifungal resistance to human health
Invasive fungal infections pose an important threat to public health and are an under-recognized
component of antimicrobial resistance, an emerging crisis worldwide. Across a period …
component of antimicrobial resistance, an emerging crisis worldwide. Across a period …
Cryptococcal meningitis
T Bicanic, TS Harrison - British medical bulletin, 2004 - academic.oup.com
Cryptococcal meningitis is a common opportunistic infection in AIDS patients, particularly in
Southeast Asia and Africa. Cases also occur in patients with other forms of …
Southeast Asia and Africa. Cases also occur in patients with other forms of …
Cryptococcus: from environmental saprophyte to global pathogen
Cryptococcosis is a globally distributed invasive fungal infection that is caused by species
within the genus Cryptococcus which presents substantial therapeutic challenges. Although …
within the genus Cryptococcus which presents substantial therapeutic challenges. Although …
[HTML][HTML] The importance of antimicrobial resistance in medical mycology
Prior to the SARS-CoV-2 pandemic, antibiotic resistance was listed as the major global health
care priority. Some analyses, including the O’Neill report, have predicted that deaths due …
care priority. Some analyses, including the O’Neill report, have predicted that deaths due …
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
Liposomal amphotericin B (AmBisome ® ; LAmB) is a unique lipid formulation of amphotericin
B. LAmB is a standard of care for a wide range of medically important opportunistic fungal …
B. LAmB is a standard of care for a wide range of medically important opportunistic fungal …
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes
Background. Cryptococcal meningitis (CM) is a leading cause of death in individuals infected
with human immunodeficiency virus (HIV). Identifying factors associated with mortality …
with human immunodeficiency virus (HIV). Identifying factors associated with mortality …
[PDF][PDF] A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete
description of specific immune biomarkers. We present here a comprehensive multi-omic …
description of specific immune biomarkers. We present here a comprehensive multi-omic …
[HTML][HTML] Antifungal combinations for treatment of cryptococcal meningitis in Africa
…, V Sini, YN Mapoure, P Mwaba, T Bicanic… - … England Journal of …, 2018 - Mass Medical Soc
Background Cryptococcal meningitis accounts for more than 100,000 human immunodeficiency
virus (HIV)–related deaths per year. We tested two treatment strategies that could be …
virus (HIV)–related deaths per year. We tested two treatment strategies that could be …
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin …
In a prospective observational study of 54 patients with human immunodeficiency virus–associated
cryptococcal meningitis, the early fungicidal activity of amphotericin B (1 mg/kg/day) …
cryptococcal meningitis, the early fungicidal activity of amphotericin B (1 mg/kg/day) …
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial
Background: Interferon-gamma (IFNγ) is of key importance in the immune response to
Cryptococcus neoformans. Mortality related to cryptococcal meningitis remains high, and novel …
Cryptococcus neoformans. Mortality related to cryptococcal meningitis remains high, and novel …